These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1132 related articles for article (PubMed ID: 16627048)

  • 1. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure].
    Nogueira JB
    Rev Port Cardiol; 1999 Jun; 18(6):635-46. PubMed ID: 10422461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke.
    Subramaniam V; Lip GY
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):703-13. PubMed ID: 19505285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy.
    Agabiti-Rosei E; Muiesan ML; Salvetti M
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S104-8. PubMed ID: 16565230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertensive heart disease.
    Diamond JA; Phillips RA
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials.
    Moser M; Hebert PR
    J Am Coll Cardiol; 1996 Apr; 27(5):1214-8. PubMed ID: 8609345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.
    Messerli FH; Ketelhut R
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S7-13. PubMed ID: 7507540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure.
    Izzo JL; Gradman AH
    Med Clin North Am; 2004 Sep; 88(5):1257-71. PubMed ID: 15331316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and reduction of left ventricular hypertrophy in the elderly.
    Lavie CJ; Milani RV; Messerli FH
    Clin Geriatr Med; 1996 Feb; 12(1):57-68. PubMed ID: 8653663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatment.
    Agabiti-Rosei E
    Blood Press Suppl; 1997; 2():13-5. PubMed ID: 9495620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG; Rupp H; Maisch B
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E; Muiesan ML
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.